MissionIR Articles
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Moving Psychedelic Therapeutics Field Forward Through Partnership
Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is sponsoring research to see if psychedelic medicine, when used with EMBARK’s supportive therapy, can help clinicians…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition
Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. According to the update, the study demonstrated…
-
MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Historically High Productivity Rates for Platosa Mine
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced second quarter 2021 production results from the Platosa Mine in Durango, Mexico. Among the highlights, the company reported silver equivalent (“AgEq”) production of 487,009 oz.…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA
CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in…
-
Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand
2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX…
-
Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment
Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Issuance of New US Patents
Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI (R) Stick disposable electronic nicotine delivery system (“ENDS”), which is intended exclusively for adults 21 and…
-
MissionIRNewsBreaks – Infobird Co. Ltd.’s (NASDAQ: IFBD) Successful SaaS Launch Paves Way for Financial Industry Expansion
Infobird (NASDAQ: IFBD), a software-as-a-service (“SaaS”) provider of artificial intelligence (“AI”) powered customer engagement solutions, today announced the successful implementation of its Intelligent Quality Inspection SaaS with one of China’s leading fintech companies. Infobird’s solution…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc.’s (NASDAQ: WTER) (CSE: WTER) Alkaline88 Water to be Available in Over 800 Gyms Nationwide via Distribution Agreement
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), today announced that it has…
-
MissionIRNewsBreaks – Why Lexaria Bioscience Corp. (NASDAQ: LEXX) Is ‘One to Watch’
Lexaria Bioscience Corp. (NASDAQ: LEXX) is the global innovator behind the patented DehydraTECH(TM) technology. DehydraTECH increases the effectiveness of lipophilic (fat-soluble) drugs and active ingredients and improves the way active pharmaceutical ingredients enter the bloodstream.…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Launch of Investment Advisor Feature on Sequire
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the release of the Investment Advisor feature. According to the update,…
-
MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Inks Definitive Agreement to Acquire 3a-Diagnostics
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, has signed a definitive agreement to acquire its exclusive diagnostics development partner 3a-diagnostics GmbH, Frickenhausen, Germany. Per the terms of the definitive agreement,…
-
MissionIRNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Executives Discuss Threedy.ai Acquisition on Proactive Investors Livestream
Nextech AR Solutions (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a diversified leading provider of augmented reality (“AR”) solutions and services, today announced that its CEO & Founder Evan Gappelberg and President & Chairman…
-
Q1 Report Shows Signs of Rising, Record-level Contracts for AmpliTech Group Inc.’s (NASDAQ: AMPG) Radio Frequency Technologies
AmpliTech Group, a designer and developer of technology that enhances radio frequency (“RF”) transmissions for satellites, 5G, IoT and other applications recently reported record order bookings and orders in progress under deadline Thaw in COVID…
-
Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results
CYBN subsidiary Adelia Therapeutics has reached earn-out milestones. Adelia’s earn-out milestones contributed to positive preclinical results with multiple proprietary psychedelic molecules. Cybin’s development of these compounds differentiates it from companies focused on naturally occurring psychedelic…
-
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships
PlantX Life recently launched as a seller on both Walmart Canada Marketplace and Hudson’s Bay Marketplace The launches appear to be leveraging the changes and trends brought about by the COVID-19 pandemic In addition, the…
-
MissionIRNewsBreaks –Splash Beverage Group Inc. (NYSE American: SBEV) Releases Updated Revenue Guidance, Forecasts 436% YoY Revenue Growth
Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, including SALT Citrus flavored tequila, released its forward-looking revenue guidance for Q3 and Q4 2021 fiscal year as well as fiscal year 2021…
-
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Partners with Agora Internet Relations Corp. for Its Marketing and Advertising
XPhyto partners with AGORA t to grow its brand and overall market share The agreement entails shares issued to AGORA on August 21, 2021 and December 31, 2021 at a price of $2.12 per share,…
-
FingerMotion Inc. (FNGR) Tackling the Market Through Unmatched Innovation and Technology
FingerMotion’s strategy is to rapidly expand its user base through organic means utilizing a broad range of innovative applications It handles over 500,000 transactions every day for its mobile payment and recharge service, all facilitated…
Search Articles
Latest Articles
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands U.S. Energy Portfolio with New York and Pennsylvania Projects
- HeartBeam Inc. (NASDAQ: BEAT) Prepares Innovative ECG Technology for Commercial Launch
- SuperCom Ltd. (NASDAQ: SPCB) U.S. Expansion Positions Company as Strong Investment Opportunity in Expanding Electronic Monitoring (‘EM’) Market
- Datavault AI Inc. (NASDAQ: DVLT) Is ‘One to Watch’